TNF Inhibitor denied for failing step therapy by Humana?

Humana's specific coverage criteria for tnf inhibitor are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Step Therapy for TNF Inhibitors — and Why You Can Appeal

Humana's step-therapy policy for TNF inhibitors requires that patients with certain inflammatory conditions try and document failure of one or more specified prior-line medications — typically conventional disease-modifying drugs or other lower-cost agents — before TNF inhibitor coverage is approved. A step-therapy denial means Humana has determined that the required prior steps have not been adequately documented in the information submitted. This is not necessarily because the steps were not completed — it is often because the documentation submitted did not clearly establish them.

## Why This Is Appealable

Step-therapy requirements have recognized exceptions, and prior completion of the required steps — even with a different prescriber or health system — qualifies you to bypass the step. Exceptions are also available when the required prior-step drugs are clinically contraindicated, have already failed, or are otherwise inappropriate for your specific situation. Many states have enacted step-therapy exception laws that create additional patient protections and response-time requirements — check whether these apply to your plan type. Under ACA §2719 and ERISA §503, you are entitled to a full-and-fair internal appeal and, if denied, an independent external review. The external review window is generally within approximately four months of denial. Expedited review is available when delay would seriously harm your health.

## The Appeal Process and Timeline

1. Request Humana's step-therapy criteria: identify exactly which prior-step medications are required and the documentation standard for each. 2. File a step-therapy exception request alongside your internal appeal: these are often combined but check Humana's process — some plans have a separate exception pathway. 3. Request peer-to-peer review: your prescriber can speak directly with Humana's medical director, which is often the fastest resolution path. 4. Escalate to external review if internal appeal fails. 5. Expedited track: available when clinically urgent.

## Documentation to Gather

• Prior medication records: for each step-therapy requirement, gather pharmacy fill records, prescriber notes, and documentation of outcomes — inadequate response, adverse effects, or the reason for discontinuation. Include dates.
• Records from prior providers: if steps were completed under a different physician or health system, obtain those records — Humana must consider them.
• Prescriber's step-therapy exception letter: your physician should address each required prior step explicitly, confirming completion or documenting the clinical basis for an exception (contraindication, prior failure with another prescriber, disease severity requiring direct biologic initiation).
• Diagnosis and severity documentation: current chart notes, specialist evaluations, and relevant test results establishing your diagnosis and current disease activity.
• FDA-approved prescribing label: confirms the approved indication.
• Humana's step-therapy policy: use it as your checklist — every step must be addressed.

## Criteria-Mapping Structure

| Step-Therapy Requirement | Evidence of Completion or Exception Basis | |---|---| | Required prior-step drug 1 | [Dates, pharmacy records, prescriber note, outcome] | | Required prior-step drug 2 (if applicable) | [Dates, pharmacy records, prescriber note, outcome] | | Exception criterion (if applicable) | [Clinical basis — contraindication, prior failure, severity] | | TNF inhibitor indication confirmed | [Diagnosis documentation; label indication] |

The most common reason step-therapy appeals succeed is that the prior steps were completed but the documentation was never compiled and submitted. Organizing that evidence is the first and most impactful step.